Targeting BET Proteins Downregulates miR-33a To Promote Synergy with PIM Inhibitors in CMML

Overview of attention for article published in Clinical Cancer Research, June 2023

Altmetric Badge

About this Attention Score

So far, Altmetric has seen 7 tweets from 7 users, with an upper bound of 9,987 followers.

RT @MrinalPatnaik: Targeting BET proteins downregulates miR-33a to promote synergy with PIM inhibitors in CMML - PubMed Fantastic work by C…

RT @MrinalPatnaik: Targeting BET proteins downregulates miR-33a to promote synergy with PIM inhibitors in CMML - PubMed Fantastic work by C…

RT @MrinalPatnaik: Targeting BET proteins downregulates miR-33a to promote synergy with PIM inhibitors in CMML - PubMed Fantastic work by C…

RT @MrinalPatnaik: Targeting BET proteins downregulates miR-33a to promote synergy with PIM inhibitors in CMML - PubMed Fantastic work by C…

This page shows the most recent tweets that mention this research output.

Click here to find out how to access more activity, including 3 additional tweets.